中性粒细胞明胶酶相关脂质运载蛋白与肿瘤的发生发展

doi:10.3969/j.issn.1004-616x.2014.02.015

癌变·畸变·突变

中性粒细胞明胶酶相关脂质运载蛋白与肿瘤的发生发展

胡永阳，刘明发，许海雄

中山大学附属汕头医院，广东汕头 515031

收稿日期:2014-01-09 修回日期:2014-03-03 出版日期:2014-03-30 发布日期:2014-03-30
通讯作者: 许海雄，E-mail：xuhx2014@126.com
作者简介:胡永阳(1982- )，男，湖北省咸宁市人，硕士研究生，研究方向：神经外科学。E-mail：hyyfeiyue@126.com
基金资助:
粤科函社字[2010]1096号，2010年广东省社会发展领域科技计划项目第151号

Received:2014-01-09 Revised:2014-03-03 Online:2014-03-30 Published:2014-03-30
Contact: 许海雄，E-mail：xuhx2014@126.com
About author:胡永阳(1982- )，男，湖北省咸宁市人，硕士研究生，研究方向：神经外科学。E-mail：hyyfeiyue@126.com
Supported by:
粤科函社字[2010]1096号，2010年广东省社会发展领域科技计划项目第151号

摘要/Abstract

摘要：

中性粒细胞明胶酶相关脂质运载蛋白(neutrophilgelatinase-associated lipocalin，NGAL)是一种与肿瘤的发生发展密切相关的糖蛋白，在脑胶质瘤、乳腺癌、食管癌、胃肠肿瘤、胰腺癌、白血病、卵巢癌等多种恶性肿瘤中出现异常表达。本文就NGAL与肿瘤发生发展的关系及可能作用机制进行综述。

胡永阳，刘明发，许海雄. 中性粒细胞明胶酶相关脂质运载蛋白与肿瘤的发生发展[J]. 癌变·畸变·突变, doi: 10.3969/j.issn.1004-616x.2014.02.015.

[1] Kjeldsen L，Johnsen AH，Sengelov H，et al. Isolation and primary structure of NGAL，a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem，1993，268(14)： 10425-10432.

[2] Flower DR. The lipocalin protein family：structure and function[J]. Biochem J，1996，318 ( Sup 11)：1-14.

[3] Kjeldsen L，Bainton DF，Sengelov H，et al. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils[J]. Blood， 1994，83(3)：799-807.

[4] Coles M，Diercks T，Muehlenweg B，et al. The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin[J]. J Mol Biol，1999，289(1)：139-157.

[5] Kjeldsen L，Cowland JB，Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse[J]. Biochim Biophys Acta，2000，1482(1/2)：272-283.

[6] Friedl A，Stoesz SP，Buckley P，et al. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression[J]. Histochem J，1999， 31(7)：433-441.

[7] Li C，Chan YR. Lipocalin 2 regulation and its complex role in inflammation and cancer[J]. Cytokine，2011，56(2)：435-441.

[8] Liu MF，Jin T，Shen JH，et al. NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis[J]. J Neurooncol，2011，104(1)：119-127.

[9] Yang J，Bielenberg DR，Rodig SJ，et al. Lipocalin 2 promotes breast cancer progression[J]. Proc Natl Acad Sci USA，2009， 106(10)：3913-3918.

[10] Zhang H，Xu L，Xiao D，et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma：significant correlation with cell differentiation and tumour invasion[J]. J Clin Pathol，2007，60(5)：555-561.

[11] Zhang XF，Zhang Y，Zhang XH，et al. Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer[J]. BMC Cancer，2009，9：134.

[12] Villalva C，Sorel N，Bonnet ML，et al. Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia[J]. Leuk Lymphoma，2008，49(5)：984-988.

[13] Ryon J，Bendickson L，Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3，a lipocalin and acute phase protein[J]. Biochem J，2002，367(Sup 1)：271-277.

[14] Barasch J，Pressler L，Connor J，et al. A ureteric bud cell line induces nephrogenesis in two steps by two distinct signals[J]. Am J Physiol，1996，271(1 Sup 2)：F50-F61.

[15] Iannetti A，Pacifico F，Acquaviva R，et al. The neutrophil gelatinase-associated lipocalin (NGAL)，a NF-kappaB-regulated gene，is a survival factor for thyroid neoplastic cells[J]. Proc Natl Acad Sci USA，2008，105(37)：14058-14063.

[16] Tong Z，Wu X，Ovcharenko D，et al. Neutrophil gelatinase-associated lipocalin as a survival factor[J]. Biochem J，2005， 391(Sup 2)：441-448.

[17] Costa D，Biticchi R，Negrini S，et al. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone[J]. Cytokine，2010，51(1)：47-52.

[18] Devireddy LR，Teodoro JG，Richard FA，et al. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation[J]. Science，2001，293(5531)： 829-834.

[19] Zheng LT，Lee S，Yin GN，et al. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells[J]. J Neurochem，2009，111(5)：1238-1251.

[20] Tong Z，Kunnumakkara AB，Wang H，et al. Neutrophil gelatinase-associated lipocalin：a novel suppressor of invasion and angiogenesis in pancreatic cancer[J]. Cancer Res，2008， 68(15)：6100-6108.

[21] Leng X，Ding T，Lin H，et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis[J]. Cancer Res，2009， 69(22)：8579-8584.

[22] Berger T，Cheung CC，Elia AJ，et al. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis[J]. Proc Natl Acad Sci US A，2010，107(7)：2995-3000.

[23] Li EM，Xu LY，Cai WJ，et al. Functions of neutrophil gelatinase-associated lipocalin in the esophageal carcinoma cell line SHEEC[J]. Acta Biochimica et Biophysica Sinica，2003， 35(3)：247-254.

[24] Hu L，Hittelman W，Lu T，et al. NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells[J]. Lab Invest，2009，89(5)：531-548.

[25] Hanai J，Mammoto T，Seth P，et al. Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells[J]. J Biol Chem，2005，280(14)：13641-13647.

[26] Bergers G，Brekken R，McMahon G，et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J]. Nat Cell Biol，2000，2(10)：737-744.

[27] Venkatesha S，Hanai J，Seth P，et al. Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells[J]. Mol Cancer Res，2006，4(11)：821-829.

[28] Devireddy LR，Gazin C，Zhu X，et al. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake[J]. Cell，2005，123(7)：1293-1305.

[29] Yang J，Goetz D，Li JY，et al. An iron delivery pathway mediated by a lipocalin[J]. Mol Cell，2002，10(5)：1045-1056.

[30] Curran S，Murray GI. Matrix metalloproteinases in tumour invasion and metastasis[J]. J Pathol，1999，189(3)：300-308.

[31] Lochter A，Sternlicht MD，Werb Z，et al. The significance of matrix metalloproteinases during early stages of tumor progression[J]. Ann NY Acad Sci，1998，857：180-193.

[32] Kolkenbrock H，Hecker-Kia A，Orgel D，et al. Progelatinase B forms from human neutrophils. complex formation of monomer/lipocalin with TIMP-1[J]. Biol Chem，1996， 377(7/8)： 529-533.

[33] Yan L，Borregaard N，Kjeldsen L，et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL[J]. J Biol Chem，2001，276(40)：37258-37265.

[34] Kubben FJ，Sier CF，Hawinkels LJ，et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer[J]. Eur J Cancer，2007，43(12)：1869-1876.

[35] Hugo H，Ackland ML，Blick T，et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression[J]. J Cell Physiol，2007，213(2)：374-383.

[36] Yang J，Moses MA. Lipocalin 2：a multifaceted modulator of human cancer[J]. Cell Cycle，2009，8(15)：2347-2352.

[37] Lim R，Ahmed N，Borregaard N，et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer：NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition[J]. Int J Cancer，2007，120(11)：2426-2434.

[38] Rankin EB，Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis[J]. Cell Death Differ，2008，15(4)：678-685.

[39] Bolignano D，Donato V，Lacquaniti A，et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias：a new protein enters the scene[J]. Cancer Lett，2010，288(1)： 10-16.

中性粒细胞明胶酶相关脂质运载蛋白与肿瘤的发生发展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵岩, 孙震晓. 二甲双胍抑制人MDA-MB-231细胞增殖及迁移的体外实验研究[J]. 癌变·畸变·突变, 2022, 34(1): 35-39.
[2]	祝欣萍, 贾迪, 林少辉, 刘晨, 李婧铱, 赵炜明. 新型多金属氧酸盐药物{BiW₈O₃₀}对肝癌SK-HEP-1细胞的抑制作用[J]. 癌变·畸变·突变, 2022, 34(1): 47-52,66.
[3]	问天娇, 李思颖, 郑颖, 崔京霞. 脂质体技术在铂类药物抗肿瘤研究中的应用[J]. 癌变·畸变·突变, 2022, 34(1): 72-74.
[4]	郭照萌, 张华, 张鹏. Orai1对鼻咽癌细胞侵袭和上皮-间充质转化的影响及其机制[J]. 癌变·畸变·突变, 2021, 33(6): 420-425.
[5]	刘宁, 梁兰兰, 李淑芳, 沈祥春, 梁冰. 氧化苦参碱对小鼠肉瘤和肝癌的体内外抗肿瘤作用[J]. 癌变·畸变·突变, 2021, 33(6): 426-429,434.
[6]	王晓舟, 李洪石, 于溪, 魏宁, 王梓瑛, 赫丽杰. 青藤碱对HPV阳性宫颈癌SiHa细胞增殖和侵袭的影响[J]. 癌变·畸变·突变, 2021, 33(6): 442-445.
[7]	王蕊, 王珩, 吴娟, 纪晓坤, 郭晓, 马阳, 杜芸. 全自动DNA图像分析系统在胰腺恶性肿瘤诊断中的价值[J]. 癌变·畸变·突变, 2021, 33(6): 451-454.
[8]	张宗敏. 甲状腺微小癌是否需要手术[J]. 癌变·畸变·突变, 2021, 33(5): 325-326.
[9]	杨兴肖, 张雪原, 邹乃祎, 单保恩, 马鸣, 祝淑钗. 干扰HMGB1基因表达对食管鳞癌细胞侵袭迁移及放射敏感性的影响[J]. 癌变·畸变·突变, 2021, 33(5): 327-333.
[10]	孙惠昕, 张茂祥, 王婉莹, 贾海晗, 宋冰冰. 2013—2017年黑龙江省肿瘤登记地区前列腺癌发病死亡情况及趋势分析[J]. 癌变·畸变·突变, 2021, 33(5): 345-348.
[11]	马亚南, 吴楠, 金焰. 肿瘤微环境与卵巢癌化疗耐药机制的研究进展[J]. 癌变·畸变·突变, 2021, 33(5): 393-395,400.
[12]	王琛瑶, 梁百慧, 吴锦源, 唐梓涵, 许小文, 尹梓健, 丁雅琼, 方雄钊, 李栢芝, 文姝佚, 程转, 詹涵, 张粤烽, 王泫哲, 何仕龙, 张可洵, 刘雅骐, 周飞, 熊兴东, 白春英, 许丽艳, 李恩民. RAC1对恶性肿瘤的调控作用及其分子机制研究进展[J]. 癌变·畸变·突变, 2021, 33(5): 401-404.
[13]	黄晓华, 牛永东, 石刚刚. 核受体FXR激活对宫颈癌CaSki细胞增殖的抑制效应及其作用机制[J]. 癌变·畸变·突变, 2021, 33(4): 302-306.
[14]	程书钧. 衰老和恶性肿瘤──防治的思考[J]. 癌变·畸变·突变, 2021, 33(3): 161-162.
[15]	郑珺文, 常晨, 郝佳洁, 蔡岩, 王明荣, 张钰. NEDD4在食管鳞癌中的表达及作用研究[J]. 癌变·畸变·突变, 2021, 33(3): 203-207,224.